[1]BioorganicandMedicinalChemistry,2010,vol.18,p.80-90
[2]AnalesdelaRealSociedadEspanoladeFisicayQuimica,SerieB:Quimica,1958,vol.54,p.471,477
[3]JournaloftheAmericanChemicalSociety,1971,vol.93,p.2897-2904
[4]BulletindesSocietesChimiquesBelges,1963,vol.72,p.202-207
[1]AnalesdelaRealSociedadEspanoladeFisicayQuimica,SerieB:Quimica,1958,vol.54,p.471,477
[1]PharmaceuticalChemistryJournal,1991,vol.25,p.296-301 Khimiko-FarmatsevticheskiiZhurnal,1991,vol.25,p.31-35
[2]PharmaceuticalChemistryJournal,1993,vol.27,p.631-634 Khimiko-FarmatsevticheskiiZhurnal,1993,vol.27,p.27-29
[3]PharmaceuticalChemistryJournal,1972,vol.6,p.451-453 Khimiko-FarmatsevticheskiiZhurnal,1972,vol.6,p.29-31
[1]JournaloftheChemicalSociety.PerkintransactionsII,1986,p.99-104
[1]SyntheticCommunications,1998,vol.28,p.4067-4075
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101